<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--Itracon-------------------------------------------------------->
<div class="bodyDiv" id="idItracon">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Itracon</h2>
    </div>
<b>Product Orientation & Presentation:</b><br>
<table class="table1">
<tr>
<td><b>Brand Name:</b><br>
Itracon
</td>
</tr>

<tr>
<td><b>Generic:</b><br>
Itraconazole
</td>
</tr>

<tr>
<td><b>Strength:</b><br>
100 mg, 200mg, 100ml Oral Solution
</td>
</tr>

<tr>
<td><b>Dosage Form:</b><br>
100mg Capsule, 200mg Tablet, 100ml Oral Suspension.
</td>
</tr>

<tr>
<td><b>Therapeutic Class:</b><br>
Antifungal
</td>
</tr>

<tr>
<td><b>Sub Therapeutic class:</b><br>
---
</td>
</tr>

<tr>
<td><b>Commercial Pack & Accessories:</b><br>
24’s
</td>
</tr>

<tr>
<td><b>Price (TP):</b><br>
17.00/ Cap, 30.00/ Cap, 580.00/ OS. 
</td>
</tr>
	
<tr>
<td><b>Flavour:</b><br>
---
</td>
</tr>

<tr>
<td><b>Indication:</b><br>
&#x2022; 
It is indicated for the treatment of Oropharyngeal Candidiasis & Esophageal Candidiasis.<br>
Itracon 100 Capsule:<br>
Tinea corporis, Tinea cruris, Tinea pedis, Tinea manuum, Vulvovaginal candidiasis, Fungal keratitis, Pityriasis versicolor, Oropharyngeal candidiasis, Onychomycosis, Histoplasmosis,<br>
Systemic Infections:<br>
Aspergillosis, Candidiasis and Cryptococcal infection when other drugs are ineffective. Antifungal prophylaxis:<br>
To prevent systemic fungal infection in severely neutropenic patients.<br>
Itracon 200 Tablet:<br>
It is an azole antifungal, indicated for the treatment of Onychomycosis of the toenail caused by Trichophyton rubrum or T. mentagrophytes. 
</td>
</tr>

<tr>
<td><b>Pregnancy:</b><br>
Pregnancy Catagory- C
</td>
</tr>

<tr>
<td><b>Lactation:</b><br>

</td>
</tr>

<tr>
<td><b>Children:</b><br>
--
</td>
</tr>

<tr>
<td><b>Brand Name Justification:</b><br>
---
</td>
</tr>

<tr>
<td><b>Brand Slogan:</b><br>
Tab & Cap:<br>
Right Choice to treat fungal infection.<br>
Oral solution:<br>
Safe & effective for infants also
</td>
</tr>

<tr>
<td><b>Dosage & Administration:</b><br>
	&#x2022; <strong>Onychomycosis:</strong><br>
	200 mg once daily for 3 months or course (pulse) of 200 mg twice daily for 7 days, subsequent courses repeated after 21 days interval; fingernails 2 courses & toenails 3 courses.<br><br>
   
   &#x2022; <strong>Vulvovaginal candidiasis:</strong><br>
	200 mg twice daily for 1 day<br><br>
   
   &#x2022; <strong>Tinea pedis:</strong><br>
	200 mg once daily for 7 days<br><br>
   
   &#x2022; <strong>Tinea corporis:</strong><br>
	200 mg once daily for 7 days<br><br>
   
   &#x2022; <strong>Pityriasis versicolor:</strong><br>
	200 mg once daily for 7 days<br><br>
   
   &#x2022; <strong>Tinea manuum:</strong><br>
	200mg once daily for 7 days <br><br>
   
   &#x2022; <strong>Oropharyngeal candidiasis:</strong><br>
	100-200 mg twice daily for 2 weeks (continue for another 2 weeks if no response; the higher dose should not be used for longer than 2 weeks if no signs of improvement)<br><br>
   
   &#x2022; <strong>Systemic candidiasis:</strong><br>
	200 mg every 12 hours for 2 days, then 200 mg once daily for max. 12 days<br><br>
   
   &#x2022; <strong>Histoplasmosis:</strong><br>
	200 mg 3 timesa day for 3 days Than 200 mg 1-2 times a day<br><br>
   
   &#x2022; <strong>Systemic cryptococcosis including cryptococcal meningitis where other antifungal drugs inappropriate or ineffective:</strong><br>
	200 mg once daily, dose increased in invasive or disseminated disease and in cryptococcal meningitis, increased to 200 mg twice daily.<br><br>
   
   &#x2022; <strong>Maintenance in HIV infected patients to prevent relapse of undertying fungal infection and prophylaxis in neutropenia when standard therapy inappropriate:</strong><br>
	200 mg once daily, then increased to 200 mg twice daily, dose Increased only if low plasma-itraconazole concentration.
</td>
</tr>

<tr>
<td><b>Key Selling Points:</b><br>

Itracon Tab & Cap:<br>
<span>&#x261E;</span> According to WHO guideline, Itraconazole is a first-line agent for the prevention and treatment of fungal infections<br>
<span>&#x261E;</span> Better then Terbinafine for the treatment of Tinea Corporis & Cruris<br>
<span>&#x261E;</span> Effectively cures different fungal infections<br>
<span>&#x261E;</span> Itraconazole appears to produce a rapid response and thus requires a shorter treatment periods<br>
<span>&#x261E;</span> Better than Ketoconazole<br><br>


Itracon Oral Solution:<br>
<span>&#x261E;</span> Better in efficacy than Fluconazole.<br>
<span>&#x261E;</span> 1st line of drug in all patients of tinea infections.<br>
<span>&#x261E;</span> The most effective drug for all types of superficial fungal infections.<br>
<span>&#x261E;</span> Safe and effective for all age groups.
<br><br>
<span>&#x261E;</span> First line of drug in all patients of tinea infections<br>
<span>&#x261E;</span> Convenient dosing ensures better patients' compliance<br>
<span>&#x261E;</span> Most superior antifungal drug in terms of clinical remission
</td>
</tr>

<tr>
<td><b>Target Doctor:</b><br>
&#x2022; Dermatologist<br>
&#x2022; Gynecologist<br>
&#x2022; Medicine specialist<br>
&#x2022; General Practitioner (GP)<br>
&#x2022; Diabetologist<br>
&#x2022; Chest specialist<br>
&#x2022; Ophthalmologist
</td>
</tr>

<tr>
<td><b>Side effects:</b><br>
&#x2022; Nausea, abdominal pain, dyspepsia, constipation, headache, dizziness, raised liver enzymes, hepatitis, cholestatic jaundice, peripheral neuropathy have been reported.
</td>
</tr>

<tr>
<td colspan="4">
<table class="table2">
<thead>
    <tr>
       <th>
	   Mode of action:
       </th>
       <th>
	   
       </th>
	   <th>
       </th>
    </tr>
</thead>

<tbody>
    <tr>
       <td> 
	   </td>
       <td>
	   Lanosterol
	   </td>
	   <td>
	   </td>
    </tr>
	<tr>
       <td>Itracon inhibits <b>&#8680;</b>
	   </td>
       <td>
	   <b>&#8681;</b>
	   </td>
	   <td><b>&#8678;</b> Lanosterol 14a-demethylase(Cytochrome P-450)
	   </td>
    </tr>
	<tr>
       <td>
	   </td>
	   <td>
	   Ergosterol (vital component of fungal & yeast cell membranes)
	   </td>
       <td>
	   </td>
    </tr>
	<tr>
       <td>
	   </td>
       <td>
	   <b>&#8681;</b><br>
	   Leads to
	   </td>
	   <td>
	   </td>
    </tr>
	<tr>
       <td><b>&#8681;</b>
	   </td>
       <td><b>&#8681;</b>
	   </td>
	   <td><b>&#8681;</b> 
	   </td>
    </tr>
	<tr>
       <td>Deteriorated membranes
	   </td>
	   <td>Disturbed enzyme activities
	   </td>
       <td>Uncoordinated synthesis of chitin
	   </td>
    </tr>
	<tr>
       <td>
	   </td>
	   <td><b>&#8681;</b>
	   </td>
       <td>
	   </td>
    </tr>
	<tr>
       <td>
	   </td>
	   <td>All together contribute to the antifungal activity
	   </td>
       <td>
	   </td>
    </tr>
</tbody>
</table>
</td>
</tr>
</table>
<br>
    <img src="img/Itracon-4.png" alt="" class="responsive-IMG" width="375" height="300">
	<br>
	<br>
<strong>Tinea Manuum:</strong> <br>
fungal infection of the hands.<br><br>

    <img src="img/Itracon-5.png" alt="" class="responsive-IMG" width="375" height="300">
	<br>
	<br>
<strong>Vulvovaginal candidiasis:</strong> <br>
Vulvovaginal candidiasis This is a yeast infection of the lower
female reproductive tract.
<br>
<br>


<b>Model Detailing:</b><br>
(Always open with social talk)<br>

Close call with sharing summary of
benefits and commitment of Rx
Opening

Dear Sir/Madam:<br>
In your daily practice, you get many fungal infected patients with Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Versicolor, Onychomycosis, Vulvovaginal candidiasis & Seborrhiec dermatitis<br>
Sir, to manage these problems, prescribe Itracon confidently because <br>
(Benefit Presentation)<br>
Dear Sir/Madam,<br>
According to International Journal of Dermatology, Itraconazole as first line of drug in all patients of tinea infections and It is better than Terbinafine & Fluconazole for the treatment of all superficial fungal infections.<br>
The complete resolution rate of Itraconazole 72%, Terbinafine 42% & Fluconazole 17%.<br>
The success rate of Itracon:<br>
• Peripheral spread absent: Itraconazole 80%, Terbinafine 38% & Fluconazole 29%.<br>
• Erithema Decreased: Itraconazole 87%, Terbinafine 41% &
Fluconazole 19%.<br>
• Scaling Decreased: Itraconazole 79%, Terbinafine 63% & Fluconazole
23%.<br>
• Spread to other body site absent: Itraconazole 69%, Terbinafine
48% & Fluconazole 23%.<br>
Itracon is the most superior drug in terms of clinical remission.<br>
Sir/Madam<br>
(Closing)<br>
Considering these benefits, may I expect 5 Rx daily in favor of Itracon?<br>
Itracon is available in all nearby shops of your chamber. So, your Rx will be honored.<br>
Thank you Sir/Madam, for giving me your valuable time.<br><br>


<b>Short Detailing:</b><br>
Dear Sir/Madam<br>
In your daily practice, you get many fungal infected patients with Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Versicolor, Onychomycosis, Vulvovaginal candidiasis & Seborrhiec dermatitis.<br>
Sir, to manage these problems, prescribe Itracon confidently because
• First line of drug in all patients' of tinea infections.<br>
• Convenient dosing ensures better patients' compliance<br>
• Most superior Antifungal drug in terms of clinical remission.<br>
Sir/Madam<br>
Considering these benefits, may I expect 5 Rx daily in favor of Itracon? Itracon is available in all nearby shops of your chamber. So, your Rx will be honored.<br>
Thank you Sir/Madam, for giving me your valuable time.<br><br>

<b>Itracon Oral Solution:</b><br>

14% of Bangladeshi children are affected by oral candidiasis which is commonly treated with Fluconazole. But in a study, <b>Fluconazole has been found to show less efficacy compared to Itraconazole.</b><br>
Itraconazole Oral Solution has a broader spectrum of activity than Fluconazole powder for suspension. It has a good safety profile which ensures good patients' compliance. With the good compliance, Itraconazole Oral Solution is cost effective in treating infantile
superficial and systemic fungal infections.<br><br>

According to WJP(World Journal of paediatrics).<br>
Safe and effective antifungal for children.<br>

Better than Fluconazole.<br>
Itraconazole: 92%
Fluconazole: 78%
Effectively cures oral candidia<br>


<b>Kew Selling Points:</b><br>
Better in efficacy than Fluconazole.<br>
1st line of drug in all patients of tinea infections.<br>
The most effective drug for all types of superficial fungal infections.<br>
Safe and effective for all age groups.<br><br>



<b>Frequently Asked Questions (FAQ):</b><br>
<b>1. Why is Itracon better than Terbinafine for the treatment of Tinea corporis & Tinea Cruris?</b><br>
Ans:<br>
Itracon is better than Terbinafine in terms of cure rate.<br>
Tinea Corporis & Cruris<br>
Itraconazole: 91.8 %<br>
Terbinafine: 71.43%<br><br>

<b>Why is Itracon preferred as a treatment option for Seborrhiec Dermatitis?</b><br>
Ans:<br>
According to the study of BSMMU, Itraconazole has significant efficacy profile to treat seborrheic dermatitis and it will be the 1st oral treatment option in future in seborrheic dermatitis. Improvement Rate 70.27%<br><br>


<b>3) Why is Itracon better than Terbinafine for the treatment of Vulvovaginal Candidiasis?</b><br>
Ans: Itracon is better than Terbinafine in terms of cure rate.
Vulvovaginal Candidiasis<br>
Itraconazole 91.8 %<br>
Terbinafine 71.43%<br><br>

<string>
	Itracon SUBA
</string>
Itraconazole USP 65 mg Capsule<<br>


Game changing SUBA technology provides the advanced antifungal delivery, almost doubling the
bioavailability of conventional Itraconazole by enhancing the solubility and absorption of the poorly
soluble as conventional Itraconazole.<br>
NAVANA PHARMA introduces<br>

Itracon SUBA<br
Itraconazole USP 65 mg Capsule<br>
<i>Advanced Itraconazole with SUBA Technology</i><br><br>

<table class="table6">
	<tr>
		<th>
			The science of SUBA
		</th>
	</tr>
	<tr>
		<th>
			The novel SUBA process
		</th>
	</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
		<td>
			utilizes a unique spray-drying technology
		</td>
	</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
		<td>
			combines the drug and a polymer solution
		</td>
	</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
		<td>
			generates an amorphous solid dispersion powder
		</td>
	</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
	<td>
		produces microencapsulated nanoparticles of
		Itraconazole dispersed in a polymer matrix
	</td>
</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
	<td>
		enhanced solubility and absorption
	</td>
</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
	<td>
		improved bioavailability
	</td>
</tr>
</table>
<br>
<table class="table6">
	<tr>
		<th>
			Unlike Conventional Itraconazole
		</th>
	</tr>
	<tr>
		<td>
			SUBA Itraconazole is less soluble in the acidic environment of
			the stomach & soluble in the higher pH of the upper small intestine
		</td>
	</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
		<td>
			results in improved absorption, even not reduced with PPI use
		</td>
	</tr>
	<tr>
		<td>
			<b>&#8681;</b>
		</td>
	</tr>
	<tr>
		<td>
			Better treatment outcomes
		</td>
	</tr>
</table>
<br>

<b>
	DOUBLE absorption & bioavailability
</b><br>
90% Bioavailable<br>
with improved overall absorption of conventional Itraconazole<br><br>


<b>Major patients achieving therapeutic blood levels</b><br>
(Higher mean Itraconazole blood C<sub>trough</sub> levels of >1,000 ng/mL)<br>

Itracon SUBA: 81%<br>
Compared to just<br>
Conventional Itraconazole: 44%<br>
<i>Ensure patients satisfaction</i><br><br>




<b>Better than Terbinafine & Fluconazole</b><br>
for the treatment of all superficial fungal infections<br>
Complete resolution<br>
Itraconazole: 72% (May be more with SUBA Itraconazole)<br>
Terbinafine: 42%<br>
Fluconazole: 17%<br>
<i>Itracon SUBA will be the most effective antifungal</i><br><br>


<b>Better responding than Terbinafine & Fluconazole</b><br>
* Clinical response rate<br>
<i>Peripheral spread Absent</i><br
80% Itraconazole<br>
38% Terbinafine<br>
29% Fluconazole<br>

<i>Erythema Decreased</i><br>
87% Itraconazole<br>
41% Terbinafine<br>
19%, Fluconazole<<br>

<i>Scaling Decreased</i><br>
79% Itraconazole<br>
63% Terbinafine<br>
23% Fluconazole<br>

<i>Not spread to other body sites</i><br>
69% Itraconazole<br>
48% Terbinafine<br>
23% Fluconazole<br>
<i>Makes the patients delighted</i><br><br>

<b>KSP</b><br>
&#8680;Therapeutic levels are achieved and
maintained in both fed and fasted conditions.<br>
&#8680;SUBA Itraconazole delivers consistent blood
levels of Itraconazole for lower patient variability.<br>
&#8680;SUBA Itraconazole is safe and well-tolerated.<br>
&#8680;Better treatment outcome Ensure patients satisfaction<br>
&#8680;1<sub>st</sub> line drug in all patients of tinea infections<br><br>

<b>Detail Talk</b><br>
Sir/Madam,<br>
আমরা আপনাকে একটা Good News দিতে চাই।<br>
আপনি জেনে থাকবেন যে, Fungal infections নির্মূল করতে 1<sub>st</sub> line drug হিসেবে পরিচিত Itraconazole. আমরা Itraconazole এর নতুন technology "SUBA বা Supper bioavailability" নিয়ে এসেছি।<br>

<b>The Game Changer</b><br>
কেনো আমরা Itracon SUBA কে game changer বলছি?<br>
প্রথমত Game Changing SUBA technology, advanced antifungal delivery প্রদান করে solubility এবং absorption বৃদ্ধির মাধ্যমে bioavailability দ্বিগুণ বাড়িয়ে দেয় ।<br>
Navana Pharma introduces,<br>
Itracon SUBA<br>
"Advanced Itraconazole with SUBA technology"<br>
	
Novel SUBA process হলো a unique spray-drying techlonogy যা drug এবং polymer solution এর combination. Amorphous solid dispersion powder 
তৈরীর মাধ্যমে Itraconazole এর nanoparticles গুলো microencapsulated করা হয়। যার ফলে solubility এবং absorption বৃদ্ধি পায়। সেই সাথে bioavailability improve করে।<br>

স্যার আপনি আরো জেনে খুশি হবেন, Itracon SUBA stomach এর acidic environment এ less soluble এবং upper small intestine এ higher pH এর মধ্যে soluble হয়। যার ফলে upper small intestine এর surface area বড় থাকার কারনে drug particles গুলো ভালোভাবে soluble হচ্ছে, as well as bioavailability improve হচ্ছে এবং PPI use করলেও absorption কমে যায় না।<br>

Itracon SUBA Double absorption, Double bioavailability নিশ্চিত করে।<br>
যেখানে Itracon SUBA এর bioavailability 90%.<br>
81% Itracon SUBA এর patients C<sub>trough</sub> levels> 1,000ng/ml achieve ,
conventional Itracon 44% patients Ctrough levels >1,000ng/ml achieve করে।<br>

স্যার আমাদের conventional Itraconzole ও কিন্তু available রয়েছে যা better than Terbinafine & Fluconazole.<br>

গবেষনাতে দেখা যায় Terbinafine & Fluconazole এর সাথে তুলনা করলে ltraconazole এর clinical response Rate অনেক বেশী। ltraconazole complete resolution 72%, যেখানে Terbinafine মাত্র 42% এবং Fluconazole মাত্র 17% complete resolution প্রদর্শন করে।<br>

Dear sir/madam<br>
Itracon 100 mg capsule, Itracon 200 mg tablet এবং Oral Solution available রয়েছে, আপনি রোগির প্রয়োজন অনুযায়ি যে কোনো dose এ ltraconazole prescribe
করতে পারবেন।<br>

Itracon SUBA, খাবার আগে ও পরে therapeutic level achieved & maintained করে। Lower patient variability তে Itracon SUBA, constant blood levels deliver করে থাকে। সেই সাথে Itracon SUBA safe & well-tolerated.<br>

Itracon SUBA,<br>
* Provides better treatment outcomes<br>
* Ensures patient’s satisfaction<br>
* 1<sub>st</sub> line drug in all patients of tinea infection<br>

Considering the excellent efficacy, safety & double bioavailability, আপনাকে অনুরোধ করবো fungal infactions এর patient কে Itracon SUBA prescribe করার জন্য|<br>
Thank you for your time.<br><br>

<b>A bridged prescribing information of Itracon SUBA:</b><br>
<b>Composition:</b><br>
	Itracon SUBA Capsule:<br>
Each capsule contains Itraconazole USP 65 mg.<br>
	Itracon 100 Capsule:<br>
Each capsule contains Itraconazole pellets equivalent to Itraconazole USP 100 mg.<br>
	Itracon 200 Tablet:<br> Each film coated tablet contains Itraconazole USP 200 mg.

	Itracon Oral Solution:<br>
Each 5 ml oral solution contains Itraconazole USP 50 mg.<br>
<b>Pharmacology:</b><br>
Itracon is a preparation of Itraconazole, an
orally active triazole antifungal agent, having broad spectrum activity and favourable pharmacokinetic profile. Itraconazole inhibits cytochrome P450 dependent enzymes resulting in impairment of the
biosynthesis of Ergosterol, a major component of the cell membrane of yeast and fungal cells.<br>
	<b>Indications:</b><br>
		Itracon Capsule & Tablet:<br>
Tinea corporis, Tinea cruris, Tinea pedis, Tinea manuum, Vulvovaginal
candidiasis, Fungal keratitis, Pityriasis versicolor, Oropharyngeal candidiasis, Onychomycosis, Histoplasmosis,
Systemic Infections:<br>
Aspergillosis, Candidiasis and Cryptococcal infection when other drugs are
ineffective.<br>
Antifungal prophylaxis:<br>
To prevent systemic fungal infection in severely neutropenic patients.<br>
Itracon Oral Solution:<br>
It is indicated for the treatment of Oropharyngeal Candidiasis & Esophageal
Candidiasis.
	<b>Dosage & Administration:</b><br>
		Itracon SUBA:<br>
65 mg twice daily for all type of fungal infections.<br>
		Itracon Tablet & Capsule:<br>
Tinea corporis, Tinea cruris:<br>
100 mg daily for 2 weeks; Tinea pedis,<br>
Tinea manuum:<br> 100 mg daily for 4 weeks; <br>
Vulvovaginal candidiasis:<br>
200 mg twice daily for 1 day. <br>
Fungal keratitis:<br>
200 mg daily for 3 weeks; <br>
Pityriasis versicolor:<br>
200 mg daily for 1 week;<br>
Oropharyngeal candidiasis:<br>
100 mg daily (200 mg for immuno compromised patients) for 15 days; <br>
Onychomycosis: <br>
200 mg daily for 3 months; or 200 mg twice daily for 7 days (course), subsequent
courses to be repeated after 21 days interval; fingemails 2 courses and toenails 3 courses; <br>
Histoplasmosis: <br>
200 mg 1-2 times daily, Systemic Infections: 200 mg once daily (Aspergillosis, Candidiasis and
Cryptococcus infection when other drugs are ineffective), increased in invasive or in cryptococcal meningitis to 200 mg twice daily, <br>
Antifungal prophylaxis: <br>
To prevent systemic fungal infection in severely
neutropenic patients 100 mg daily. <br>
Itracon Oral Solution: <br>
This solution should be vigorously swished in the mouth (10 ml at a time) for several seconds and swallowed. The recommended dosage of Itracon
oral solution for Oropharyngeal Candidiasis is 200 mg (20 ml) daily for 1 to 2 weeks. The recommended dosage of Itracon oral solution for Esophageal Candidiasis is 100 mg (10 ml) daily for a minimum
treatment of 3 weeks.<br>
	<b>Child Dose:</b><br>
	5 mg/kg once daily for 14 days. For oral use only (for 1 month to 11 years of age) Should be taken after meal or as directed by the physician.<br>
		<b>Contraindication:</b><br>
			The drug is contraindicated in patients with known history of hypersensitivity to it. The drug is also contraindicated in pregnant women and patients with known severe hepatic disease. It is also contraindicated with
Rifampicin therapy.<br>
			<b>Warnings and Precautions:</b><br>
				Hepatic enzyme value should be monitored in patients with pre-existing hepatic function abnormalities. It should also be monitored periodically in all patients
receiving continuous treatment for more than one month or at any time a patient develops sign and symptoms suggestive liver dysfunction.<br>
				<b>Side Effects:</b><br>
					Nausea, abdominal pain, dyspepsia, constipation,
headache, dizziness, raised liver enzymes, hepatitis, cholestatic jaundice, peripheral neuropathy have been reported.<br>
	<b>Use in Pregnancy and Lactation:</b><br>
		Not recommended during pregnancy & lactation.<br>
		
		<b>Use in Children & Adolescents:</b><br>
		Tablet & Capsule:<br>
		The efficacy and safety of Itraconazole tablet & capsule have not been established in paediatric patients and adolescents.<br>
		
<b>Oral Solution:</b><br>
			Safe for paediatric patients (from 1 month age & above).<br>

<b>Drug Interaction:</b><br>
		Itraconazole inhibits the metabolism of Cyclosporine and Warfarin. Interaction with Terfenadine, Phenobarbitone, Midazolam has been reported.<br>
		
	<b>Overdosage:</b><br>
		There is no experience of overdosage with Itraconazole.<br>
		
		<b>Storage:</b><br>
		Itracon Capsule & Tablet:<br>
		Store below 30°C, protected from light & in a dry place.<br>
		Itracon Oral Solution:<br>
		Store below 25°C, protected from light & in a dry place. Do not freeze. Keep all medicines out of the reach of children.<br>

<b>Packing:</b><br>
Itracon SUBA Capsule:<br>
Each box contains 3X10 capsules in Alu-Alu blister pack and an insert.<br>
	Itracon 100 Capsule:<br>
		Each box contains 3X10 capsules in Alu-Alu blister pack and an insert.<br>
Itracon 200 Tablet Each box contains 3X10 tablets in Alu-Alu blister pack and an insert.<br>
Itracon Oral Solution:<br>
Each box contains 100 ml oral solution in glass bottle, a measuring cup and an insert.<br>
Ref: 1.tolsura.com 2. Koregol SC et al. Int J Res Dermatol. 2021 May:7(3)435-430<br><br>


<b>Prescribing information:</b><br>
<b>Composition:</b><br>
Itracon Oral Solution:<br>
Each 5 ml oral solution contains Itraconazole USP 50 mg.<br>
Itracon 100 Capsule:<br>
Each capsule contains Itraconazole pellets equivalent to Itraconazole USP 100 mg.<br>
Itracon 200 Tablet:<br>
Each film coated tablet contains Itraconazole USP 200 mg.<br>
<b>Pharmacology:</b><br>
Itracon is a preparation of Itraconazole, an orally active triazole antifungal agent, having broad spectrum activity and favourable pharmacokinetic profile. Itraconazole inhibits cytochrome P450 dependent enzymes resulting in impairment of the biosynthesis of Ergosterol, a major component of the cell membrane of yeast and fungal cells.<br>
<b>Indications:</b><br>
Itracon Oral Solution:<br>
It is indicated for the treatment of Oropharyngeal Candidiasis & Esophageal Candidiasis.<br>
Itracon 100 Capsule:<br>
Tinea corporis, Tinea cruris, Tinea pedis, Tinea manuum, Vulvovaginal candidiasis, Fungal keratitis, Pityriasis versicolor, Oropharyngeal candidiasis, Onychomycosis, Histoplasmosis,<br>
Systemic Infections:<br>
Aspergillosis, Candidiasis and Cryptococcal infection when other drugs are ineffective. Antifungal prophylaxis:<br>
To prevent systemic fungal infection in severely neutropenic patients.<br>
Itracon 200 Tablet:<br>
It is an azole antifungal, indicated for the treatment of Onychomycosis of the toenail caused by Trichophyton rubrum or T. mentagrophytes.<br>
<b>Dosage & Administration:</b><br>
Itracon Oral Solution:<br>
This solution should be vigorously swished in the mouth (10 ml at a time) for several seconds and swallowed. The recommended dosage of Itracon oral solution for Oropharyngeal Candidiasis is 200 mg (20 ml) daily for 1 to 2 weeks. The recommended dosage of Itracon oral solution for Esophageal Candidiasis is 100 mg (10 ml) daily for a minimum treatment of 3 weeks. Child Dose: 5 mg/kg once daily for 14 days. For oral use only.<br>
Itracon Tablet & Capsule:<br>
Tinea corporis. Tinea cruris: 100 mg daily for 2 weeks.<br>
Tinea pedis, Tinea manuum: 100 mg daily for 4 weeks.<br>
Vulvovaginal candidiasis: 200 mg twice daily for 1 day.<br>
Fungal keratitis: 200 mg daily for 3 weeks.<br>
Pityriasis versicolor: 200 mg daily for 1 week.<br>
Oropharyngeal candidiasis: 100 mg daily (200 mg for immunocompromised patients) for
15 days.<br>
Onychomycosis: 200 mg daily for 3 months; or 200 mg twice daily for 7 days (course), subsequent courses to be repeated after 21 days interval; fingernails 2 courses and toenails 3 courses. Histoplasmosis: 200 mg 1-2 times daily.<br>
Systemic Infections: 200 mg once daily (Aspergillosis, Candidiasis and Cryptococcus infection when other drugs are ineffective), increased in invasive or in cryptococcal meningitis to 200 mg twice daily.<br> Antifungal prophylaxis: <br>
To prevent systemic fungal infection in severely neutropenic patients 100 mg daily or as directed by the physician.<br>
<b>Contraindication:</b><br>
The drug is contraindicated in patients with known history of hypersensitivity to it. The drug is also contraindicated in pregnant women and patients with known severe hepatic disease. It is also contraindicated with Rifampicin therapy.<br>
<b>Warnings and Precautions:</b><br>
Hepatic enzyme value should be monitored in patients with pre-existing hepatic function abnormalities. It should also be monitored periodically in all patients receiving continuous treatment for more than one month or at any time a patient develops sign and symptoms suggestive liver dysfunction.<br>
<b>Side Effects:</b><br>
Nausea, abdominal pain, dyspepsia, constipation, headache, dizziness, raised liver enzymes, hepatitis, cholestatic jaundice, peripheral neuropathy have been reported.<br>
Use in Pregnancy and Lactation:</b><br>
Not recommended during pregnancy & lactation. Use in Children & Adolescents: The efficacy and safety of Itraconazole capsule have not been established in paediatric patients and adolescents.<br>
<b>Drug Interaction:</b><br>
Itraconazole inhibits the metabolism of Cyclosporine and Warfarin. Interaction with Terfenadine, Phenobarbitone, Midazolam has been reported. Overdosage: There is no experience of overdosage with Itraconazole.<br>
<b>Storage:</b><br>
Store below 30°C, protected from light & in a dry place. Keep all medicines out of the reach of children.<br>
<b>Packing:</b><br>
Itracon 100 Capsule:<br>
Each box contains 6X4 capsules in Alu-Alu blister pack and an insert.<br>
Itracon 200 Tablet:<br>
Each box contains 2X10 tablets in Alu-Alu blister pack and an insert.<br>
Itracon Oral Solution:<br>
Each box contains 100 ml oral solution in glass bottle, a measuring cup and an insert.<br><br>

<div class="link-btn" onclick="window.open('https://drive.google.com/file/d/1g_ZxEqtd5i1f5K1CLgysTFHml0Fd2lbe/view?usp=sharing', '_blank')">
Itracon SUBA PPT.pdf
</div>

</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Itracon</div></center><!--End Line---->
</body>
</html>